Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an update.
Clarity Pharmaceuticals Ltd. has announced a change in substantial holding, indicating that State Street Corporation and its subsidiaries have ceased to be substantial holders in the company as of October 22, 2025. This change in holding may impact the company’s operations and market positioning, as substantial holders can influence corporate governance and strategic decisions.
The most recent analyst rating on (AU:CU6) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,467,426
Technical Sentiment Signal: Buy
Current Market Cap: A$1.8B
See more data about CU6 stock on TipRanks’ Stock Analysis page.